REUTERS: Mallinckrodt Plc said on Thursday it planned to spin off its specialty generics business to shareholders by the second half of 2019, capping a two-year long effort to look for options for the unit. The new company will also include constipation drug Amitiza, which Mallinckrodt added ...
- Youth in S’pore films friends with burning supermarket trolley
- Life after OPEC: Qatar to invest $20 billion into US energy in major expansion
- Estimating the swing against PAP
- Bumpy Road To Thailand’s General Election
- Here’s how different media reported gay S’porean man’s successful adoption of surrogate child
- Google Flights lands in Singapore
- This Brazilian Bank Is Using Ethereum to Issue a Stablecoin